Catalent
CTLT
#1737
Rank
โ‚ฌ9.89 B
Marketcap
54,52ย โ‚ฌ
Share price
0.00%
Change (1 day)
3.45%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ0.28 Billion

According to Catalent's latest financial reports the company has โ‚ฌ0.28 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30โ‚ฌ0.25 B-50.04%
2022-06-30โ‚ฌ0.51 B-37.04%
2021-06-30โ‚ฌ0.81 B-3.84%
2020-06-30โ‚ฌ0.84 B179.08%
2019-06-30โ‚ฌ0.30 B-13.29%
2018-06-30โ‚ฌ0.35 B30.32%
2017-06-30โ‚ฌ0.26 B115.51%
2016-06-30โ‚ฌ0.12 B-8.16%
2015-06-30โ‚ฌ0.13 B150.09%
2014-06-30โ‚ฌ54.33 M-33.55%
2013-06-30โ‚ฌ81.75 M-25.55%
2012-06-30โ‚ฌ0.10 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Supernus Pharmaceuticals
SUPN
โ‚ฌ0.24 B-16.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.14 B-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚ฌ1.75 B 510.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚ฌ0.27 B-3.67%๐Ÿ‡บ๐Ÿ‡ธ USA